Turra V, Manzi J, Rombach S, Zaragoza S, Ferreira R, Guerra G
Transpl Int. 2025; 38:13716.
PMID: 39926359
PMC: 11802283.
DOI: 10.3389/ti.2025.13716.
Erkan S, Avci T, Gundogdu R, Ozarslan F, Yabanoglu H, Yavuz Colak M
Acta Endocrinol (Buchar). 2025; 20(2):170-178.
PMID: 39845754
PMC: 11750227.
DOI: 10.4183/aeb.2024.170.
Barnes A, White R, Venables H, Lam V, Vaidhyanath R
Ultrasound. 2024; :1742271X241299220.
PMID: 39654847
PMC: 11625399.
DOI: 10.1177/1742271X241299220.
Borysewicz-Sanczyk H, Bossowski F, Anikiej K, Sawicka B, Michalak J, Dzieciol J
Front Endocrinol (Lausanne). 2024; 15:1486285.
PMID: 39634183
PMC: 11614656.
DOI: 10.3389/fendo.2024.1486285.
Alzahrani R, Ezzi S, Alghamdi M, Alsudais A, Yahya N, Aljuaid F
Cureus. 2024; 16(11):e72837.
PMID: 39624546
PMC: 11608908.
DOI: 10.7759/cureus.72837.
Lobectomy vs Total Thyroidectomy With Ipsilateral Lateral Neck Dissection for N1b Intermediate-Risk Papillary Thyroid Carcinoma.
Saito Y, Matsuzu K, Abdelhamid Ahmed A, Inoue K, Shibuya H, Matsui A
JAMA Otolaryngol Head Neck Surg. 2024; 151(2):105-112.
PMID: 39602155
PMC: 11826362.
DOI: 10.1001/jamaoto.2024.3860.
ASO Author Reflections: The Minimum Number of Examined Lymph Nodes in Thyroidectomy.
Wei B, Chang S, Wang W
Ann Surg Oncol. 2024; 32(2):1189-1190.
PMID: 39556182
DOI: 10.1245/s10434-024-16535-8.
Misrepresented multiple endocrine neoplasia 2: Do the British Thyroid Association guidelines accurately predict thyroid cancer risk in high-risk groups with multiple endocrine neoplasia 2? A case series.
Kamyab A, Weller A, Hulley K, Bano G
Ultrasound. 2024; :1742271X241260225.
PMID: 39555152
PMC: 11563518.
DOI: 10.1177/1742271X241260225.
Prediction of lateral lymph node metastasis with short diameter less than 8 mm in papillary thyroid carcinoma based on radiomics.
Wang Y, Zhang S, Zhang M, Zhang G, Chen Z, Wang X
Cancer Imaging. 2024; 24(1):155.
PMID: 39548590
PMC: 11566407.
DOI: 10.1186/s40644-024-00803-7.
Incidence and gender difference of brain metastases in newly diagnosed follicular thyroid cancer patients.
Zhang R, Li W, Wang H, Zhang W, Chai J, Chang P
Eur Thyroid J. 2024; .
PMID: 39531475
PMC: 11737522.
DOI: 10.1530/ETJ-24-0093.
How Many Lymph Nodes are Enough in Thyroidectomy? A Cohort Study Based on Real-World Data.
Wei B, Tan H, Chen L, Chang S, Wang W
Ann Surg Oncol. 2024; 32(2):1149-1157.
PMID: 39521741
DOI: 10.1245/s10434-024-16391-6.
Role of [F]FDG PET/CT in the management of follicular cell-derived thyroid carcinoma.
Zajkowska K, Cegla P, Dedecjus M
Cancer Imaging. 2024; 24(1):147.
PMID: 39468677
PMC: 11514821.
DOI: 10.1186/s40644-024-00791-8.
Management of medullary thyroid cancer based on variation of carcinoembryonic antigen and calcitonin.
Wang B, Huang J, Chen L
Front Endocrinol (Lausanne). 2024; 15:1418657.
PMID: 39449744
PMC: 11499115.
DOI: 10.3389/fendo.2024.1418657.
Core needle biopsy: an efficacious adjunct to cytological diagnosis in thyroid tumours suspected of anaplastic carcinoma - single-centre experience.
Bakula-Zalewska E, Kwapisz M, Goralski P, Dlugosinska J, Galczynski J, Dedecjus M
Contemp Oncol (Pozn). 2024; 28(2):167-171.
PMID: 39421712
PMC: 11480912.
DOI: 10.5114/wo.2024.142468.
Physicians' preferencesfor radioiodine treatment of differentiated thyroid cancer in Brazil: an observational study.
Padovani R, Pansani I, Marone M, Vaisman F, Maia A, Dora J
Arch Endocrinol Metab. 2024; 68:e230228.
PMID: 39420903
PMC: 11196101.
DOI: 10.20945/2359-4292-2023-0228.
Prognostic factors for aggressiveness in subcentimeter papillary thyroid carcinoma: impact of tumor size and lymph node metastases.
Kayhan Y, Azizova L, Yilmaz M, Bakis M, Kefeli M, Kan E
Arch Endocrinol Metab. 2024; 68:e230422.
PMID: 39420875
PMC: 11326733.
DOI: 10.20945/2359-4292-2023-0422.
Management of follicular thyroid carcinoma.
Yamazaki H, Sugino K, Katoh R, Matsuzu K, Kitagawa W, Nagahama M
Eur Thyroid J. 2024; 13(5).
PMID: 39419099
PMC: 11558955.
DOI: 10.1530/ETJ-24-0146.
Rethinking the prognosis model of differentiated thyroid carcinoma.
He L, Xiang J, Zhang H
Front Endocrinol (Lausanne). 2024; 15:1419125.
PMID: 39403579
PMC: 11471587.
DOI: 10.3389/fendo.2024.1419125.
Thermal ablation for Bethesda III and IV thyroid nodules: current diagnosis and management.
Chan W, Chiang P, Lin A, Chang Y, Lin W
Ultrasonography. 2024; 43(6):395-406.
PMID: 39397446
PMC: 11532522.
DOI: 10.14366/usg.24083.
Shared Decision Making for Radioiodine Therapy and the Actual Pattern of Care in Intermediate-Risk Differentiated Thyroid Carcinoma.
Eilsberger F, Luster M, Reiners C
Front Nucl Med. 2024; 1:797522.
PMID: 39355644
PMC: 11440860.
DOI: 10.3389/fnume.2021.797522.
